jRCT2071260010招募中不适用
A phase I clinical trial of KSP-0930
未提供0 个研究点目标入组 262 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 262
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 18age old over 至 65age old not（—）
- 性别
- All
入选标准
- •At the time of informed consent, male aged >=18 and =<45 years or females aged >=50 and <65 years at least 12 months after the last menstrual period.
- •Japanese participants with a BMI >=18.5 to <25 kg/m2 or Caucasian participants with a BMI >=18.5 to <30 kg/m
- •Males who body weight >=50 to <90 kg and females who body weight >=45 to <90 kg.
排除标准
- •Participants with abnormal findings on medical examination, vital signs, or 12-lead ECG, judged by the principal investigator or subinvestigator to be clinically significant.
研究者
相似试验
招募中
不适用
A phase I clinical trial of KSP-0576interstitial cystitis/bladder pain syndromejRCT2071250154256
尚未招募
1 期
A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological MalignanciesRelapsed or Refractory EBV-associated Hematological MalignanciesNCT07532746Kousai Bio Co., Ltd.55
招募中
1 期
A study testing a new treatment called TK-6302 for the first time in people with advanced cancers that have a genetic marker called HLA-A02:01 and a tumour protein called PRAME.2025-521603-46-00T-Knife GmbH24
招募中
1 期
A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy ParticipantsOverweight , ObesityNCT07443059Beijing QL Biopharmaceutical Co.,Ltd40
招募中
1 期
SKB103 for Injection in Advanced Solid TumorsNCT07459998Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.277